BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30.07.2025

FDA Announces Generic Drug User Fee Rates for Fiscal Year 2026

The Food and Drug Administration (FDA) is setting fees for abbreviated new drug applications, drug master files, and other generic drug-related services for fiscal year 2026, as mandated by the Generic Drug User Fee Amendments of 2022.

Source: Federal Register — Food and Drug AdministrationOpen original release →